
| Salt Composition: | Estradiol (2mg) |
| Manufacturer: | Ridhima Biocare |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Megplace H 2mg Tablet is a hormone replacement therapy used to treat menopause symptoms, estrogen deficiency, and osteoporosis. Megplace H 2mg Tablet is a female sex hormone (estrogen) used as hormone replacement therapy (HRT) to treat symptoms associated with menopause such as hot flushes, vaginal dryness, and itching. It also addresses estrogen deficiency and helps in preventing osteoporosis in postmenopausal women. The most common side effects include headaches, breast pain, irregular vaginal bleeding, abdominal cramps, nausea, vomiting, and hair loss. It is important to consult a doctor before starting this medication, especially if there is a history of unexplained vaginal bleeding or blood clots. Pregnant or breastfeeding women should also seek medical advice before use.
Megplace H 2mg Tablet contains estrogen, a female sex hormone. It works by replacing estrogen that is normally produced by the body, preventing symptoms such as hot flushes, vaginal burning, dryness, and itching caused due to lack of estrogen.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Megplace H 2mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Alcohol
Caution is advised when consuming alcohol with Megplace H 2mg Tablet. Please consult your doctor.
Breastfeed
Megplace H 2mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy
Megplace H 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Please consult your doctor.